HomeTagsAlvotech

Tag: Alvotech

European Commission authorises Amneal’s omalizumab...

The European Commission granted marketing authorisation for...

European Commission authorises Amneal’s omalizumab biosimilar Adcomfo

The European Commission granted marketing authorisation for Adcomfo (omalizumab), a biosimilar referencing Xolair, on 12 November 2026. The product was developed by Kashiv BioSciences in collaboration with Alvotech. The decision followed a positive opinion from the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), adopted on 17 September 2026, and expands the product’s regulatory presence in European markets. Adcomfo is a recombinant DNA-derived humanised monoclonal antibody that selectively binds to immunoglobulin E (IgE), thereby reducing the amount of free IgE available to trigger the allergic cascade. Amneal...

European Commission authorises...

The European Commission granted marketing authorisation for Adcomfo (omalizumab), a biosimilar referencing Xolair, on 12 November 2026. The product was developed by Kashiv BioSciences...
spot_img

Create a website from scratch

With Newspaper Theme you can drag and drop elements onto a page and customize them to perfection. Try it out today and create the perfect site to express yourself!